FDA clears NDSsi wireless HD video technology

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
NDS Surgical Imaging (NDSsi) has received the FDA's 510(k) clearance for ZeroWire Duo, a class II medical-grade wireless high-definition (HD) video technology for minimally-invasive surgery, gastrointestinal and interventional suites.

The San Jose, Calif.-based company said its features of the ZeroWire Duo HD video transmission system include:
  • Memory-enabled pairing system that makes installation;
  • Medical grade image quality with HD video (1080p60);
  • Designed and tested in accordance with applicable standards to not interfere with other equipment in the operating room (OR);
  • Signal reliability by virtue of UWB radio technology; and
  • Interfaces with other image sources and surgical monitors in the OR.

Justine Varieur Cadet

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.